Global Crude Heparin Market Research Report 2020
Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
The top five manufacturers which are Shenzhen Hepalink, Pharma Action (Tönnies Group), Fengrun Biological, Nanjing King-friend, Aspen Oss held 37% of the market, in terms of crude heparin revenue in 2018.
The global Crude Heparin market is valued at 2438 million US$ in 2020 is expected to reach 6512.7 million US$ by the end of 2026, growing at a CAGR of 14.9% during 2021-2026.
This report focuses on Crude Heparin volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Crude Heparin market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Crude Heparin market is segmented into
Pig Intestine Mucosa Heparin
Bovine Heparin and Others
Pig intestine mucosa heparin is almost the only used and efficient types and took 99.6% market share in 2018.
Segment by Application
UFH
LMWH
LMWH is the largest consumer group, with market share of 89% in 2018.
Global Crude Heparin Market: Regional Analysis
The Crude Heparin market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Crude Heparin market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Crude Heparin Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Crude Heparin market include:
Shenzhen Hepalink Pharmaceutical Group Co., Ltd
Bioiberica
Sanofi
Fengrun Biological Technology Co., Ltd.
Nanjing King-friend Biochemical Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Changzhou Qianhong Biopharma Co.,Ltd
Aspen Oss
Hepac (Darling Ingredients)
Yantai Dongcheng Biochemicals Co., Ltd
Huaian MDC Pharmaceutical Co., Ltd
The top five manufacturers which are Shenzhen Hepalink, Pharma Action (Tönnies Group), Fengrun Biological, Nanjing King-friend, Aspen Oss held 37% of the market, in terms of crude heparin revenue in 2018.
The global Crude Heparin market is valued at 2438 million US$ in 2020 is expected to reach 6512.7 million US$ by the end of 2026, growing at a CAGR of 14.9% during 2021-2026.
This report focuses on Crude Heparin volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Crude Heparin market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Crude Heparin market is segmented into
Pig Intestine Mucosa Heparin
Bovine Heparin and Others
Pig intestine mucosa heparin is almost the only used and efficient types and took 99.6% market share in 2018.
Segment by Application
UFH
LMWH
LMWH is the largest consumer group, with market share of 89% in 2018.
Global Crude Heparin Market: Regional Analysis
The Crude Heparin market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Crude Heparin market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Crude Heparin Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Crude Heparin market include:
Shenzhen Hepalink Pharmaceutical Group Co., Ltd
Bioiberica
Sanofi
Fengrun Biological Technology Co., Ltd.
Nanjing King-friend Biochemical Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Changzhou Qianhong Biopharma Co.,Ltd
Aspen Oss
Hepac (Darling Ingredients)
Yantai Dongcheng Biochemicals Co., Ltd
Huaian MDC Pharmaceutical Co., Ltd
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
